Introduction to Cancer Hospital of Shandong First Medical University (Shandong Cancer Institute,Shandong Cancer Hospital)
Cancer Hospital of Shandong First Medical University (Shandong Cancer Institute,Shandong Cancer Hospital), also known as Shandong Cancer Hospital and Shandong Cancer Prevention and Research Institute, was established in 1958. It falls under the jurisdiction of Shandong First Medical University (Shandong Academy of Medical Sciences), with the Shandong Provincial Health Commission acting as its business department in charge. It serves as a provincial-level cancer prevention and research center that integrates medical care, scientific research, teaching, healthcare and prevention, and provides cross-provincial services. The hospital is recognized as a national clinical key specialty construction unit in oncology, a selected unit for the national project on enhancing the diagnosis and treatment capabilities of difficult and complicated diseases, a national drug clinical trial institution, a prospective president unit of the Chinese Society of Clinical Oncology (a national first-level society), a prospective chairman unit of the Radiation Therapy Branch of the Chinese Medical Association, and the Shandong Clinical Medical Center. It functions as the Cancer Center of Shandong Province, the Quality Control Center for Cancer in Shandong Province, and is affiliated with the Shandong Anti-Cancer Association, the Shandong Clinical Oncology Society, and the Shandong Cancer Prevention Office.
The hospital spans nearly 500 mu with a construction area of 339,700 square meters and a total assets value of nearly 6 billion yuan. It employs over 2,600 staff and has 1,950 registered beds, serving more than 400,000 outpatient visits annually. The hospital has 1 academician of the Chinese Academy of Engineering, over 10 distinguished experts in contact with the central government, central health consultation experts, recipients of the State Council Special Allowance, young scholars of the Chang Jiang Scholars Program, and experts from the "Ten Thousand Talent Program". Additionally, it boasts more than 70 talents including Taishan Scholar Climbing Plan experts, Taishan Scholar Specially-invited Experts, young Taishan Scholars, provincial young and middle-aged experts with outstanding contributions, leaders in health and wellness from the Qilu region, and outstanding young scholars.
The discipline construction of the hospital is specialized and subdivided, offering 20 specialties and 45 inpatient wards such as oncology radiation therapy, surgery, internal medicine, gynecological oncology, interventional radiology, and pediatric oncology. It also has over 10 medical technology departments and basic research laboratories. These have led to the creation of comprehensive treatment advantages through the cooperation of various technologies, including surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, endocrinology, traditional Chinese medicine, interventional procedures, and minimally invasive techniques. The hospital houses a number of key specialties and is recognized as a national clinical key specialty construction unit, a key laboratory in Shandong Province, a key discipline in medicine and health in the province, a provincial high-quality specialty, a provincial clinical key specialty, and was among the first batch to be selected for the "Taishan Scholar Climbing Plan" and the "Taishan Scholar Positions". It is also known as the "Shandong Radiation Therapy Center for Cancer". The radiology oncology team has been honored by the provincial Party committee and government as one of the "Top Ten Outstanding Innovation Teams in Shandong Province", receiving collective first-class merits and the title of "National Workers' Pioneer". Additionally, the hospital has been awarded the "National May Day Labor Medal".
The hospital places a strong emphasis on high-level and large-scale scientific research. In the past decade, it has won over 20 national and provincial-and-ministerial-level science and technology awards, including 3 second-place National Science and Technology Progress Awards, 1 He Liang He Li Science and Technology Progress Award, 1 highest award for Science and Technology in Shandong Province, and 8 first-place provincial and ministerial awards. In recent years, it has undertaken more than 140 major national projects, including being awarded three times consecutively for national major projects on the prevention and control of chronic diseases. It has twice won the "Best International Paper Award" of the American Society for Radiation Oncology (ASTRO) meeting, becoming the only institution to do so. On average, nearly 300 SCI papers are published each year over the past three years. In 2017, the total number of SCI papers published with a score above 5 made the hospital rank first among the provincial medical institution, and second for the number of papers published with a score above 3. The hospital has invested nearly 100 million yuan in purchasing high-end basic research equipment, such as sMRI, PET-CT, and precision irradiator for small animals, establishing an internationally leading platform in radiology immunology, molecular imaging, artificial intelligence, and public services. It possesses a range of high-end radiation therapy equipment guided by imaging technology, such as proton radiation therapy system, magnetic resonance-guided accelerators, cyber knives, and TOMO, representing the international advanced level. Currently, it is the hospital with the most extensive and advanced radiation therapy equipment in China, serving the highest number of diagnostic and treatment cases.
As a first-level training unit for doctoral and master students on the first-level discipline of clinical medicine, it serves clinical medicine doctoral students from 18 universities in China. It is also a teaching site for doctoral students on first-level disciplines such as public health, computer technology, and nuclear science for 4 universities in the country. The hospital has 97 supervisors for doctoral and master students, and recruits over 130 doctoral and master students annually.
Leveraging its role as a provincial cancer hospital model, the hospital has established collaborative relationships with nearly a hundred hospitals both inside and outside the province, actively exploring a tiered diagnosis and treatment model for cancer. It continually strengthens domestic and international exchanges and cooperation, having signed a Memorandum of Cooperation for a sister hospital collaboration with the MD Anderson Cancer Center in USA, which ranks first in the world. On average, more than ten leading scholars and business backbones are sent abroad each year for further education and training for over a year. The hospital has also established business collaborations with countries including the USA, the UK, Russia, and Japan.
The Shandong Province Technology Innovation and Clinical Transformation Platform Project (Proton Center), as the "No.1 Project" and a detonation project of the Jinan International Medical Science Center, was officially inaugurated on April 1, 2021. It obtained the national medical device registration certificate on November 1, 2023, and was formally put into clinical use. The construction speed set a "top of world". The second phase of the project, the heavy ion neutron project, has started construction and will be the first to establish an international top-tier comprehensive cancer radiation therapy technology system. Within five years, it aims to achieve the ambitious goal of becoming "internationally leading".